Evidence map›Paper›PMID 36292620›Full record

ArticleGenes2022

The Association between the

Aoto Saito, Mika Saito, Kathleen Y de Almeida, Hiroki Homma, Minoru Deguchi, Ayumu Kozuma, Naoyuki Kobatake, Takanobu Okamoto, Koichi Nakazato, Naoki Kikuchi

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. TheMetabolites · 2024
    Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Aoto SaitoGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.
Mika SaitoGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.
Kathleen Y de AlmeidaGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.ORCID 0000-0002-8568-7897
Hiroki HommaGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.
Minoru DeguchiGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.
Ayumu KozumaGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.
Naoyuki KobatakeFaculty of Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.
Takanobu OkamotoGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.
Koichi NakazatoGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.ORCID 0000-0002-2479-5771
Naoki KikuchiGraduate School of Health and Sport Science, Nippon Sport Science University, Tokyo 158-8508, Japan.ORCID 0000-0001-5901-7307
Nippon Sport Science University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rs671 polymorphism is associated with the enzymatic activity of aldehyde dehydrogenase 2 (ALDH2), which is weakened by the A allele in East Asians. We recently reported the association of this polymorphism with the athletic status in athletic cohorts and the muscle strength of non-athletic cohorts. Therefore, we hypothesized the association of

Indexed as

Athletic PerformancePolymorphism, Single NucleotideAldehyde Dehydrogenase, MitochondrialAthletesFemaleHumansJapanMaleAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanathletic performancegenotypemitochondrial aldehyde dehydrogenase 2polymorphismpower/strength athletes

Identifiers

PMID36292620
PMCPMC9601891
OpenAlexW4297348726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.